TScan Therapeutics, Inc.
TCRXNasdaqCIK 1783328HealthcareFiscal year ends Dec 31
Reports and events: 102 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2608:07 ET | DEF 14A | Proxy statementPeriod 2026-11-20 | 0001193125-26-431045 |
| 2026-10-1616:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-424198 |
| 2026-09-3017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-409199 |
| 2026-09-1108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-388631 |
| 2026-09-0207:22 ET | 8-K | 2.05 Exit or disposal costs; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-379343 |
| 2026-08-1817:00 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-355664 |
| 2026-08-1207:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-345749 |
| 2026-08-1207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345732 |
| 2026-06-2207:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276693 |
| 2026-05-2216:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-236862 |
| 2026-05-0607:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-207572 |
| 2026-05-0607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-207549 |
| 2026-04-1707:30 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001193125-26-160304 |
| 2026-04-0207:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-138973 |
| 2026-03-0407:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-089884 |
| 2026-03-0407:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-089871 |
| 2026-01-1207:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009771 |
| 2025-11-2616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-300538 |
| 2025-11-1207:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-275933 |
| 2025-11-1207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-275889 |
| 2025-11-0306:35 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261612 |
| 2025-09-0907:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-198768 |
| 2025-08-2016:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-184083 |
| 2025-08-1207:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106919 |
| 2025-08-1207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106915 |
| 2025-07-0207:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-154336 |
| 2025-05-1407:01 ET | DEF 14A | Proxy statementPeriod 2025-06-30 | 0001193125-25-119378 |
| 2025-05-0607:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063968 |
| 2025-05-0607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063959 |
| 2025-03-0507:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-033077 |
| 2025-03-0507:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-033071 |
| 2024-12-2607:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-284671 |
| 2024-12-2307:27 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-283673 |
| 2024-12-1008:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-273985 |
| 2024-11-2108:05 ET | 8-K | 3.02 Unregistered sale of equity | 0000950142-24-002817 |
| 2024-11-1207:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124575 |
| 2024-11-1207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124558 |
| 2024-11-0107:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-249124 |
| 2024-08-1207:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095066 |
| 2024-08-1207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095063 |
| 2024-06-1407:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-161151 |
| 2024-05-1307:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058198 |
| 2024-05-1307:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058194 |
| 2024-04-3016:07 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001193125-24-125066 |
| 2024-04-2316:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-050607 |
| 2024-04-1706:25 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-098509 |
| 2024-04-1616:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-097764 |
| 2024-04-1007:30 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-091386 |
| 2024-04-0808:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-089164 |
| 2024-03-0607:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-026875 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 08:08 ET. Listed shows no prices and gives no investment advice.